Published in Stem Cells Dev on August 01, 2010
Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res (2012) 1.73
Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair (2011) 1.13
Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res (2012) 1.06
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Gut microbiota and the paradox of cancer immunotherapy. Front Immunol (2014) 0.95
Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. Stem Cells Dev (2010) 0.94
NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer. Dig Dis Sci (2014) 0.92
Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther (2015) 0.90
Biodistribution of mesenchymal stem/stromal cells in a preclinical setting. Stem Cells Int (2013) 0.84
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? Breast Cancer Res (2012) 0.83
Sonic hedgehog mediates the proliferation and recruitment of transformed mesenchymal stem cells to the stomach. PLoS One (2013) 0.82
Mesenchymal stem cells induce epithelial proliferation within the inflamed stomach. Am J Physiol Gastrointest Liver Physiol (2014) 0.81
Role of Sonic Hedgehog signaling during progression from inflammation to cancer in the stomach. World J Gastrointest Pathophysiol (2011) 0.78
P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms. Int J Oncol (2013) 0.78
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci (2016) 0.76
Techniques for following labeled cells in vivo: use of X/Y FISH, techniques to optimize fluorescent detection, and beta-galactosidase detection. Methods Mol Biol (2012) 0.75
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell (2001) 12.42
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature (2009) 9.75
Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature (2009) 8.70
The three Es of cancer immunoediting. Annu Rev Immunol (2004) 8.20
Adaptive immunity maintains occult cancer in an equilibrium state. Nature (2007) 8.14
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature (2009) 7.96
Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med (2007) 6.47
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med (2003) 6.00
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet (2002) 3.89
The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci (2004) 3.83
Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer (1985) 3.69
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell (2005) 3.68
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol (2004) 3.34
TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev (2006) 3.14
Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest (1993) 2.89
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res (2004) 2.86
Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer (1987) 2.73
CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol (2003) 2.70
Cancer without disease. Nature (2004) 2.65
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther (2008) 2.50
Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene (2004) 2.47
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res (2005) 2.20
Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells (2003) 2.03
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02
CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res (2003) 2.00
Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene (2004) 1.97
ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer (1995) 1.94
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res (2005) 1.84
Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res (2006) 1.68
Immunology. Regulating the regulators. Science (2003) 1.64
Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res (2005) 1.60
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res (2007) 1.58
Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev (2000) 1.54
Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res (2006) 1.54
Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev (2006) 1.43
Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol (2000) 1.39
APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis (2000) 1.32
Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer (1989) 1.21
A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology (2005) 1.16
Breast-cancer stromal cells with TP53 mutations. N Engl J Med (2008) 1.10
Matrix metalloproteinases target protease-activated receptors on the tumor cell surface. Cancer Cell (2005) 1.07
Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci (1998) 0.97
Reduced expression of APC and DCC gene protein in breast cancer. Histopathology (1999) 0.90
Under pressure: stromal fibroblasts change their ways. Cell (2005) 0.89
Breast-cancer stromal cells with TP53 mutations. N Engl J Med (2008) 0.84
Breast-cancer stromal cells with TP53 mutations. N Engl J Med (2008) 0.83
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell (2008) 4.43
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol (2003) 3.97
T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature (2002) 3.93
Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol (2003) 3.72
Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem (2002) 3.58
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest (2003) 3.52
Host lifestyle affects human microbiota on daily timescales. Genome Biol (2014) 2.99
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol (2005) 2.85
Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem (2007) 2.81
CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol (2003) 2.70
An intraoral fixation method of endotracheal tube using the surgical suture in pediatric patients. Paediatr Anaesth (2008) 2.66
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest (2012) 2.64
A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem (2002) 2.61
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol (2008) 2.39
Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol (2003) 2.26
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res (2005) 2.20
Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol (2007) 2.14
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02
CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res (2003) 2.00
Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer (2010) 1.98
Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology (2003) 1.96
MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol (2005) 1.85
Pattern recognition receptors and the innate immune response to viral infection. Viruses (2011) 1.82
Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol (2008) 1.80
Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep (2014) 1.79
Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun (2004) 1.74
Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res (2012) 1.73
Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun (2004) 1.72
Castration eliminates conspecific aggression in group-housed CD1 male surveillance mice (Mus musculus). J Am Assoc Lab Anim Sci (2012) 1.72
Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science (2006) 1.71
Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res (2006) 1.68
Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol (2010) 1.63
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res (2007) 1.58
Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology (2010) 1.56
Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res (2006) 1.54
STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A (2013) 1.53
Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol (2010) 1.52
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis (2007) 1.51
Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J Exp Med (2012) 1.49
Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology (2010) 1.46
A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol (2004) 1.41
Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One (2013) 1.40
Cancer inflammation and regulatory T cells. Int J Cancer (2010) 1.40
Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med (2006) 1.40
Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology (2005) 1.39
Hypertrophic pulmonary osteoarthropathy disappearance despite lung cancer relapse. South Med J (2008) 1.38
Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol (2006) 1.35
Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J Immunol (2007) 1.34
Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling. J Cell Biol (2003) 1.32
Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun (2007) 1.31
Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol (2009) 1.28
MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol (2010) 1.28
Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol (2007) 1.28
Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood (2008) 1.24
Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol (2008) 1.24
Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol (2010) 1.23
Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res (2007) 1.23
Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells (2008) 1.22
UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog (2010) 1.22
C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. J Infect Dis (2011) 1.21
Microbial reprogramming inhibits Western diet-associated obesity. PLoS One (2013) 1.21
Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J Leukoc Biol (2004) 1.20
Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol (2005) 1.19
Roles for inflammation and regulatory T cells in colon cancer. Toxicol Pathol (2009) 1.18
Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis (2004) 1.15
Toll like receptors and viruses. Rev Med Virol (2006) 1.14
Mdm2-p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin. Dev Biol (2011) 1.13
Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J Immunol (2004) 1.13
NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol (2003) 1.12
Dermal papilla-induced hair differentiation of adult epithelial stem cells from human skin. Physiol Genomics (2004) 1.12
Therapeutic targeting of C-terminal binding protein in human cancer. Cell Cycle (2010) 1.12
MyD88 intrinsically regulates CD4 T-cell responses. J Virol (2008) 1.11
Alcohol-induced IL-1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation. J Leukoc Biol (2013) 1.10
Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One (2010) 1.10
Differential expression of cyclin D1 in the human hair follicle. Am J Pathol (2003) 1.10
Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol (2010) 1.10
T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner. J Immunol (2003) 1.09
Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol (2011) 1.09